[The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report]. / La pentoxifylline, un épargneur de corticoïdes dans le traitement de la sarcoïdose : à propos d'une observation.
Rev Pneumol Clin
; 74(1): 48-51, 2018 Feb.
Article
en Fr
| MEDLINE
| ID: mdl-29122398
INTRODUCTION: The pentoxifylline seems to have some effects on immune cells by inhibiting tumor necrosis factor alpha (TNFα). Its role as a sparing corticosteroids in the treatment of sarcoidosis remains to be defined. CLINICAL CASE: We present the case of a patient with sarcoidosis corticodependent despite the use of azathioprine. It was finally improved clinically, functionally and by a thoracic computed tomography with addition of pentoxifylline. CONCLUSION: When the tolerance of the pentoxifylline is good and there is not a bleeding risk, the benefit-risk in the long term might be interesting in some patients with sarcoidosis corticodependent.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pentoxifilina
/
Inhibidores de Fosfodiesterasa
/
Sarcoidosis
/
Factor de Necrosis Tumoral alfa
/
Glucocorticoides
Límite:
Female
/
Humans
/
Middle aged
Idioma:
Fr
Revista:
Rev Pneumol Clin
Año:
2018
Tipo del documento:
Article
Pais de publicación:
Francia